That is both a simple and very complicated question....because right now Resverlogix as a company is fundamentally worthless I would argue.  The only value rests with Apabetalone and its potential....but how do you stick a value on potential?  Will BETonMACE succeed?  Will it fail?  If it does succeed what will that success look like?  Will we get good numbers on MACE RRR but not so good  on eGFR and Cognition?  

I might write more on this...but there is no simple slide rule.  Fundamentally speaking RVX has the same "hard value" it had a month or so back when the Market Cap was around $1 billion CDN in my opinion.